Business Context and Reporting Period
This Form 8-K Current Report was filed by LeMaitre Vascular, Inc. on June 9, 2017, covering events occurring on June 5, 2017, and June 7, 2017. The filing primarily addresses the results of the 2017 Annual Meeting of Stockholders, the resignation of a senior executive, and voluntary compensation reductions by the CEO.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only specific financial figures disclosed relate to executive compensation arrangements:
- Relocation Reimbursement: Up to $74,800 for Peter R. Gebauer.
- Transition Salary: $10,000 per year for Peter R. Gebauer (part-time role).
- CEO Salary Reduction: George W. LeMaitre is foregoing his salary for the remainder of 2017, retaining only the minimum amount required by Department of Labor regulations ($455 per week).
Material Changes and Corporate Actions
Executive Departure and Transition
Peter R. Gebauer, President, International, and Managing Director of LeMaitre Vascular GmbH, submitted his resignation effective September 30, 2017. He will continue in his current roles until that date. A Transition and Employment Agreement was executed on June 7, 2017, providing for his part-time employment as International Operations Specialist until August 15, 2018.
Annual Meeting Results
On June 5, 2017, the Company held its Annual Meeting with 17,206,665 shares present (out of 18,702,388 entitled to vote). Stockholders approved the following:
- Election of Directors: John A. Roush and Michael H. Thomas were elected as Class II directors for three-year terms.
- Auditor Ratification: Grant Thornton LLP was ratified as the independent registered public accounting firm for 2017.
CEO Compensation Voluntary Reduction
George W. LeMaitre, Chairman and CEO, voluntarily agreed to forego his salary for the remainder of 2017 (except for the statutory minimum) and relinquish his 2017 bonus opportunity.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of market risks. The primary contingency noted is that the Company's obligations under the Transition Agreement with Mr. Gebauer are subject to his continued employment through September 30, 2017. Full texts of the Separation and Transition Agreements are expected to be filed in the Form 10-Q for the quarter ending June 30, 2017.
Investor Verification Checklist
- Verify the full terms of the Separation and Transition Agreements with Peter R. Gebauer in the upcoming Form 10-Q.
- Confirm the impact of the CEO's salary and bonus forfeiture on the Company's 2017 operating expenses.
- Monitor the transition of International Operations leadership following Mr. Gebauer's departure in September 2017.
- Review the voting breakdown for the election of directors to assess shareholder sentiment.